A Goal Too Far: Rethinking HbA1c Targets for Diabetes Treatment episode artwork

EPISODE · Jun 19, 2018 · 29 MIN

A Goal Too Far: Rethinking HbA1c Targets for Diabetes Treatment

from JAMA Clinical Reviews

The American College of Physicians just changed its guidance for how aggressively to treat type 2 diabetes, relaxing the HbA1c goal to something below 8 rather than 6.5 or 7 as other organizations recommend. This has stirred up substantial controversy. The rationale behind this decision is presented in this podcast. Related article

Episode metadata supplied by the publisher feed · Published Jun 19, 2018

Embed this episode

NOW PLAYING

A Goal Too Far: Rethinking HbA1c Targets for Diabetes Treatment

0:00 29:24

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Clinical Reviews?

This episode is 29 minutes long.

When was this JAMA Clinical Reviews episode published?

This episode was published on June 19, 2018.

Can I download this JAMA Clinical Reviews episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!